Finance

Lists
AURA:NASDAQ
Aura Biosciences Inc
6,17 USD
-1,59%
(-0,100) 1D
6,17 USD
0,00% (0,00)
After hours
Closed: 14-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AURA...
Open
6,21 USD
High
6,28 USD
Low
6,08 USD
Mkt. cap
639,86 млн
Avg. vol.
945,73 миң
Volume
1,00 млн
52-wk high
9,54 USD
52-wk low
4,73 USD
EPS
-1,76 USD
Beta
0,41
Shares outstanding
103,70 млн
No. of employees
113
Open
6,21 USD
High
6,28 USD
Low
6,08 USD
Mkt. cap
639,86 млн
Avg. vol.
945,73 миң
Volume
1,00 млн
52-wk high
9,54 USD
52-wk low
4,73 USD
EPS
-1,76 USD
Beta
0,41
Shares outstanding
103,70 млн
No. of employees
113
News stories
From web sources and news partners
About Aura Biosciences Inc
CEO-
Employees113
Founded2009
HeadquartersБостон, Массачусетс, Америка Кошмо Штаттары
Sector-
Analyst ratings
Based on 2 analysts giving stock ratings to AURA in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for AURA in the last 3 months.
Highest
Current 6,17 USD
23,00 USD (+272,77%)
Average
20,50 USD (+232,25%)
Lowest
18,00 USD (+191,73%)
Analyst
Recommendation
Action
Price target
Projected
Date
Oliver McCammon
LifeSci Capital
Buy
Maintained
23,00 USD
+272,8%
08/12/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
18,00 USD
+191,7%
08/12/2026
Andrew Berens
Leerink Partners
Buy
Reiterated
-
-
06/02/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
05/11/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
15,00 USD
+143,1%
04/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
22,18 млн
21,90 млн
27,96 млн
30,75 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,73 млн
5,34 млн
6,91 млн
17,32 млн
Operating expense
27,91 млн
27,24 млн
34,87 млн
48,07 млн
Total operating expenses
27,91 млн
27,24 млн
34,87 млн
48,07 млн
Operating income
-27,91 млн
-27,24 млн
-34,87 млн
-48,07 млн
Other non operating income
-13,00 миң
149,00 миң
2,00 миң
154,00 миң
EBT including unusual items
-26,10 млн
-25,54 млн
-33,67 млн
-45,61 млн
EBT excluding unusual items
-26,10 млн
-25,54 млн
-33,67 млн
-45,61 млн
Income tax expense
26,00 миң
15,00 миң
11,00 миң
29,00 миң
Effective tax rate
-0,10%
-0,06%
-0,03%
-0,06%
Other operating expenses
-
-
-
-
Net income
-26,13 млн
-25,56 млн
-33,68 млн
-45,64 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1,82 млн
1,54 млн
1,19 млн
2,31 млн
Interest expense
-
-
-
-
Net interest expenses
1,82 млн
1,54 млн
1,19 млн
2,31 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-27,63 млн
-26,96 млн
-34,59 млн
-47,81 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору